H1-2 - H1.2 linker histone, cluster member Gene

Also Known as H1C; H1.2; H1F2; H1s-1; HIST1H1C

Species: Homo sapiens

Gene Type: protein coding
Gene ID: 3006

About H1-2

Cytogenetic location: 6p22.2 Genomic coordinates (GRCh38): 6:26,055,740-26,056,470 (from NCBI)

This gene has 1 transcript (splice variant), 81 orthologues and 9 paralogues.

Summary

Histones are basic nuclear proteins responsible for nucleosome structure of the chromosomal fiber in eukaryotes. Two molecules of each of the four core histones (H2A, H2B, H3, and H4) form an octamer, around which approximately 146 bp of DNA is wrapped in repeating units, called nucleosomes. The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H1 family. Transcripts from this gene lack polyA tails but instead contain a palindromic termination element. This gene is found in the large histone gene cluster on chromosome 6. [provided by RefSeq, Aug 2015]

H1-2 Products (1)

mRNA Protein Name
NM_005319.4 NP_005310.1 histone H1.2

Gene Ontology

  • Molecular Function
  • Cellular Component
Molecular Function GO Annotation Evidence References Source
enables chromatin DNA binding IDA
IDA: Inferred from direct assay
15911621 GOA
enables protein binding IPI
IPI: Inferred from physical interaction
22720776 GOA
Cellular Component GO Annotation Evidence References Source
located in euchromatin IDA
IDA: Inferred from direct assay
15911621 GOA
located in nucleus IDA
IDA: Inferred from direct assay
21383955 GOA
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

H1-2 Protein Structure

Linker_histone

Linker_histone: linker histone H1 and H5 family (38 - 109)

  • 0
  • 100
  • 200
  • 213 a.a.
Protein Preferred Names Protein Names

histone H1.2

  • H1 histone family, member 2

H1-2 Protein-protein interaction Information

Type
Protein Name Protein ID Interactor Interactor Species Interactor ID Detection Method References
Intra
H1-2 P16403 H2BC21 Homo sapiens Q16778
Crosslink
30021884
Intra
H1-2 P16403 H2AC21 Homo sapiens Q8IUE6
Crosslink
30021884
Intra
H1-2 P16403 H2AC21 Homo sapiens Q8IUE6
Anti Tag CoIP
33961781
Intra
H1-2 P16403 DDX21 Homo sapiens Q9NR30
Anti Tag CoIP
33961781
Intra
H1-2 P16403 FTSJ3 Homo sapiens Q8IY81
Anti Tag CoIP
33961781
Intra
H1-2 P16403 BAZ1B Homo sapiens Q9UIG0
Anti Tag CoIP
33961781
Cross: Cross-species interaction Intra: Intraspecies interaction

H1-2 Antibodies

Cat. No. Product Name Application Reactivity
HY-P80158 Histone H1.2 Antibody (YA383) WB, IHC-P, ICC/IF, ChIP, IF-Tissue Human, Mouse, Rat

Related Diseases

Diseases Alias
Supranuclear Palsy, Progressive, 1

  • Progressive Supranuclear Palsy

  • Steele-Richardson-Olszewski Syndrome

  • Supranuclear Palsy, Progressive

  • Progressive Supranuclear Ophthalmoplegia

  • Psp

  • PSNP1

  • Familial Progressive Supranuclear Palsy

  • Richardson'S Syndrome

  • Psp Syndrome

  • Progressive Supranuclear Palsy 1

  • Supranuclear Palsy Progressive

  • Ophthalmoplegia, Supranuclear, Progressive

  • Steele-Richardson-Olszewksi Syndrome
Pick Disease Of Brain

  • Pick Disease

  • Pick'S Disease

  • Pick Disease Of The Brain

  • Lobar Atrophy Of Brain

  • Dementia With Lobar Atrophy And Neuronal Cytoplasmic Inclusions

  • Behavioral Variant Of Frontotemporal Dementia

  • Dementia In Pick'S Disease

  • Lobar Atrophy Of The Brain

  • Bvftd

  • Bv-Ftd

  • PIDB

  • Picks Disease
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

  • Approval
  • Pre-clinical Phase

Approval

Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-13219 Tepoxalin Inhibitor 98.46% Unkown
HY-107833 A40926 Inhibitor 94.10% Unkown

Pre-clinical Phase

Bioactive Molecules (159)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-109582 ADT-OH 98.55% Unkown
HY-W027592 1H-1,2,4-Triazol-3-amine 99.96% Unkown
HY-77001 5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid 99.99% Unkown
HY-23033 Tempone-H 98.0% Unkown
HY-128147 MetAP-2-IN-6 Inhibitor 99.55% Unkown
HY-I0896 P-Toluenesulfonic Acid (3S,5R)-5-(2,4-Difluorophenyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]oxolan-3-ylmethyl Ester 99.94% Unkown
HY-103149 SB-216641A Antagonist 98.04% Unkown
HY-W007685 Methyl 1H-1,2,4-triazole-5-carboxylate 97.50% Unkown
HY-W113615 4-Phenyl-1H-1,2,3-triazole Inhibitor 99.35% Unkown
HY-WAA0156 1-(Pyrrolidin-3-yl)-1H-1,2,4-triazole oxalate 98.0% Unkown
HY-P1507 Fibrinogen Binding Inhibitor Peptide 99.86% Unkown
HY-W012991 3-Mercapto-1,2,4-triazole 99.78% Unkown
HY-Z7147 Efinaconazole analogue-1 Control 99.0% Unkown
HY-181527S N-(4-((3-Methoxy-4-(1-(methyl-d3)-1H-1,2,4-triazol-3-yl)pyridin-2-yl)amino)-5-propionylpyridin-2-yl)cyclopropanecarboxamide 99.93% Unkown
HY-181938S (S)-N-(4-((3-Methoxy-4-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-2-yl)amino)-5-propionylpyridin-2-yl)spiro[2.2]pentane-1-carboxamide-d3 / Unkown
HY-W006393 [2,2'-Bipyridine]-6,6'(1H,1'H)-dione / Unkown
HY-W089929 2-(3-(Pyridin-4-yl)-1H-1,2,4-triazol-5-yl)pyridine ≥98.0% Unkown
HY-W012383 1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone 99.86% Unkown
HY-W023897 3-(1H-1,2,4-Triazol-1-yl)benzoic Acid 98.12% Unkown
HY-W042692 5-Pyridin-4-yl-1H-1,2,4-triazol-3-amine 99.63% Unkown
HY-W112477 4-(4H-1,2,4-Triazol-4-yl)phenol ≥97.0% Unkown
HY-W543267 1,3,5-Tri(1H-1,2,3-triazol-5-yl)benzene / Unkown
HY-N10765 Salvinolone Inhibitor 98.51% Unkown
HY-41749 1H-1,2,3-Triazole-4,5-dicarboxylic acid ≥95.0% Unkown
HY-RS05947 H1-2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W016149 4,5-Dichloro-3H-1,2-dithiol-3-one Inhibitor 98.0% Unkown
HY-W075138 1,4-Di(4H-1,2,4-triazol-4-yl)benzene / Unkown
HY-W075154 2-(1H-1,2,4-Triazol-1-yl)benzene-1,3,5-tricarboxylic acid / Unkown
HY-W075298 4-(4H-1,2,4-Triazol-4-yl)benzoic acid 99.20% Unkown
HY-W075569 Tris(4-(4H-1,2,4-triazol-4-yl)phenyl)amine 99.61% Unkown
HY-W103735 3,5-Diphenyl-4H-1,2,4-triazole 98.58% Unkown
HY-W329835S 2-((1H-1,2,4-Triazol-1-yl)methyl)-4-(4-chlorophenyl)-2-phenylbutanenitrile-d5 98.18% Unkown
HY-132698S 2-Amino-4-chloro-N-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]benzamide-d3 / Unkown
HY-141723S (4R,5R)-5-(2,4-Difluorophenyl)-4-methyl-5-(1H-1,2,4-triazol-1-ylmethyl)-2-oxazolidinone-d3 / Unkown
HY-141726S rel-(αR,βR)-β-(2,4-Difluorophenyl)-β-hydroxy-α-methyl-1H-1,2,4-triazole-1-butanoic acid-d3 / Unkown
HY-W098127S Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate-d2 / Unkown
HY-13689G Go 6983 (GMP) / Unkown
HY-14988 I-A09 Inhibitor / Unkown
HY-149975 AMPA receptor modulator-4 Activator / Unkown
HY-153184 GalNAc-L96 free base / Unkown
HY-N17641 3,4,-Dihydro-5-methoxyl-6-methyl-2-phenyl-2H-1-benzopyran-7-ol / Unkown
HY-W002957 4-(1H-1,2,4-triazol-1-yl)benzoic acid / Unkown
HY-W021499 2-(3-Methyl-1H-1,2,4-triazol-5-yl)pyridine / Unkown
HY-W074655 4,4′,4′′-(1,3,5-Benzenetriyl)tris[1H-1,2,3-triazole-1-acetic acid] / Unkown
HY-W075114 1,3,5-Tris(4-(4H-1,2,4-triazol-4-yl)phenoxy)benzene / Unkown
HY-W075127 1,4-Bis((1H-1,2,4-triazol-1-yl)methyl)benzene / Unkown
HY-W075135 1,4-Di(1H-1,2,4-triazol-1-yl)benzene / Unkown
HY-W075152 2-((1H-1,2,4-Triazol-1-yl)methyl)benzoic acid / Unkown
HY-W075155 2-(1H-1,2,4-Triazol-1-yl)benzoic acid / Unkown
HY-W075194 2,5-Di(1H-1,2,4-triazol-1-yl)terephthalic acid ≥95.0% Unkown
HY-W075212 2,6-Di(1H-1,2,4-triazol-1-yl)pyridine / Unkown
HY-W075240 3-(4H-1,2,4-Triazol-4-yl)benzoic acid / Unkown
HY-W075242 3,3'-(4-Amino-4H-1,2,4-triazole-3,5-diyl)dibenzoic acid ≥97.0% Unkown
HY-W075259 3,5-Di(pyridin-2-yl)-4H-1,2,4-triazol-4-amine / Unkown
HY-W075260 3,5-Di(pyridin-3-yl)-4H-1,2,4-triazol-4-amine ≥98.0% Unkown
HY-W075261 3,5-Di(pyridin-4-yl)-4H-1,2,4-triazol-4-amine / Unkown
HY-W075275 4-((1H-1,2,4-Triazol-1-yl)methyl)benzoic acid 99.04% Unkown
HY-W075324 4,4'-(4-Amino-4H-1,2,4-triazole-3,5-diyl)dibenzoic acid / Unkown
HY-W075381 4,4'-Di(4H-1,2,4-triazol-4-yl)-1,1'-biphenyl / Unkown
HY-W075394 4,6-Di(1H-1,2,4-triazol-1-yl)isophthalic acid / Unkown
HY-W075406 5-(1H-1,2,4-Triazol-1-yl)isophthalic acid / Unkown
HY-W075451 5,5'-Di(1H-1,2,4-triazol-1-yl)-[1,1'-biphenyl]-3,3'-dicarboxylic acid / Unkown
HY-W075493 Di(1H-1,2,4-triazol-1-yl)methane / Unkown
HY-W075608 4,4'-(1H-1,2,4-Triazole-3,5-diyl)dibenzoic acid / Unkown
HY-W075616 4,4'-(1-(Pyridin-4-ylmethyl)-1H-1,2,4-triazole-3,5-diyl)dipyridine / Unkown
HY-W075617 4,4'-(1-Benzyl-1H-1,2,4-triazole-3,5-diyl)dipyridine / Unkown
HY-W090156 2-(4H-1,2,4-Triazol-4-yl)acetic acid / Unkown
HY-W1049756 5-(3-Ethyl-4H-1,2,4-triazol-4-yl)isophthalic acid / Unkown
HY-W1049788 N1,N4-di(4H-1,2,4-triazol-4-yl)terephthalamide / Unkown
HY-W1049790 2,7-Di(4H-1,2,4-triazol-4-yl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone / Unkown
HY-W1049795 1,6-di(4H-1,2,4-triazol-4-yl)hexane / Unkown
HY-W1049797 (4H-1,2,4-Triazole-3,5-diyl)dimethanol / Unkown
HY-W1049879 4'-(1H-1,2,4-Triazol-1-yl)-[1,1'-biphenyl]-3,5-dicarboxylic acid / Unkown
HY-W112072 Tris(4-(1H-1,2,4-triazol-1-yl)phenyl)amine / Unkown
HY-W112266 5,5'-(1H-1,2,3-triazole-1,4-diyl)diisophthalic acid / Unkown
HY-W112304 5-(4H-1,2,4-triazol-4-yl)isophthalic acid / Unkown
HY-W112338 1,1′-(1,6-Hexanediyl)bis[1H-1,2,4-triazole] / Unkown
HY-W112339 1,2-Di(4H-1,2,4-triazol-4-yl)ethane / Unkown
HY-W112372 4,4'-Di(1H-1,2,4-triazol-1-yl)-1,1'-biphenyl / Unkown
HY-W112382 4,4'-Bi-4H-1,2,4-triazole 98.92% Unkown
HY-W112447 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bis[benzoic acid] / Unkown
HY-W112459 4,4'-((4H-1,2,4-Triazol-4-yl)azanediyl)dibenzoic acid / Unkown
HY-W112506 4-((1H-1,2,4-Triazol-3-yl)methyl)benzonitrile / Unkown
HY-W112657 2,4,6-Tri(4H-1,2,4-triazol-4-yl)-1,3,5-triazine / Unkown
HY-W112702 2-(1H-1,2,4-Triazol-1-yl) terephthalic acid / Unkown
HY-W112718 1,1'-(9,9-Dimethyl-9H-fluorene-2,7-diyl)bis(1H-1,2,4-triazole) / Unkown
HY-W112719 4,4''-Di(1H-1,2,4-triazol-1-yl)-1,1':4',1''-terphenyl / Unkown
HY-W112720 1,2-Di(1H-1,2,4-triazol-1-yl)ethane / Unkown
HY-W112754 1,4-Bis(1H-1,2,4-triazole-1-yl)butane / Unkown
HY-W112756 1,4-Bis((4H-1,2,4-triazol-4-yl)methyl)benzene / Unkown
HY-W112844 1,1,2,2-Tetrakis(4-(1H-1,2,4-triazol-1-yl)phenyl)ethene / Unkown
HY-W112954 1,3-Di(1H-1,2,4-triazol-1-yl)propane / Unkown
HY-W113031 2-(4-(4H-1,2,4-Triazol-4-yl)phenyl)aceticacid ≥98.0% Unkown
HY-W124407 4-(4H-1,2,4-Triazol-4-yl)benzaldehyde 98.21% Unkown
HY-W249138 4,4'-((4-(4H-1,2,4-Triazol-4-yl)phenyl)azanediyl)dibenzoic acid / Unkown
HY-W249346 1,3-Di(4H-1,2,4-triazol-4-yl)benzene / Unkown
HY-W249348 N1,N1,N4,N4-Tetrakis(4-(4H-1,2,4-triazol-4-yl)phenyl)benzene-1,4-diamine / Unkown
HY-W249350 1,4-Di(1H-1,2,3-triazol-5-yl)benzene / Unkown
HY-W249362 4,4'-(1-(Pyridin-3-ylmethyl)-1H-1,2,4-triazole-3,5-diyl)dipyridine / Unkown
HY-W249363 3,4,5-Tris(4-bromophenyl)-4H-1,2,4-triazole / Unkown
HY-W249380 9-Butyl-2,7-di(1H-1,2,4-triazol-1-yl)-9H-carbazole / Unkown
HY-W249818 5,5',5''-(4,4',4''-(Benzene-1,3,5-triyl)tris(1H-1,2,3-triazole-4,1-diyl))triisophthalic acid / Unkown
HY-W291423 3,5-Di(pyrazin-2-yl)-4H-1,2,4-triazol-4-amine / Unkown
HY-W388902 3,5-Bis(trifluoromethyl)-4H-1,2,4-triazole / Unkown
HY-W456303 3-Methyl-2-(5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)pyridine / Unkown
HY-W456304 1,4-Bis(5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)butane / Unkown
HY-W456314 2,5-Bis(5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)thiophene / Unkown
HY-W456316 1,3-Di(4H-1,2,4-triazol-4-yl)propane / Unkown
HY-W456319 2-(5-(Pyridin-4-yl)-4H-1,2,4-triazol-3-yl)pyrazine / Unkown
HY-W456324 4,4'-(5'-(4-(4H-1,2,4-Triazol-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(4H-1,2,4-triazole) / Unkown
HY-W456328 3,5-Bis(5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)pyridine / Unkown
HY-W456471 3,5-Bis(5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)pyridine / Unkown
HY-W456472 3,5-Dipropyl-4H-1,2,4-triazole / Unkown
HY-W456473 1,2-Bis((1H-1,2,4-triazol-1-yl)methyl)benzene / Unkown
HY-W456474 4,4'-Bis((1H-1,2,4-triazol-1-yl)methyl)-1,1'-biphenyl / Unkown
HY-W456544 5-(4-((3,5-Dicarboxyphenoxy)methyl)-1H-1,2,3-triazol-1-yl)isophthalic acid / Unkown
HY-W456586 1-(4-Carboxyphenyl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid / Unkown
HY-W456593 5-(3-Methyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-4-yl)isophthalic acid / Unkown
HY-W456595 5,5'-(4,4'-(Pyridine-3,5-diyl)bis(1H-1,2,3-triazole-4,1-diyl))diisophthalic acid / Unkown
HY-W456596 5,5'-(4,4'-(1,3-Phenylene)bis(1H-1,2,3-triazole-4,1-diyl))diisophthalic acid / Unkown
HY-W456597 5,5'-(4,4'-(1,4-Phenylene)bis(1H-1,2,3-triazole-4,1-diyl))diisophthalic acid / Unkown
HY-W456598 5,5',5''-(4,4',4''-(Nitrilotris(methylene))tris(1H-1,2,3-triazole-4,1-diyl))triisophthalic acid / Unkown
HY-W543318 3',5'-Di(1H-1,2,4-triazol-1-yl)-[1,1'-biphenyl]-3,5-dicarboxylicacid / Unkown
HY-W543322 2-(Hydroxymethyl)-2-(4H-1,2,4-triazol-4-yl)propane-1,3-diol / Unkown
HY-W543324 5'-(4-(4H-1,2,4-Triazol-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-dicarboxylicacid / Unkown
HY-W543325 4,4'-((5-(4-(4H-1,2,4-Triazol-4-yl)phenoxy)-1,3-phenylene)bis(oxy))dibenzoicacid / Unkown
HY-W543327 4-(1H-1,2,3-Triazol-5-yl)benzaldehyde / Unkown
HY-W543328 3,5-Bis(2-methylphenyl)-1H-1,2,4-triazole / Unkown
HY-W543684 4,7-Di(1H-1,2,4-triazol-1-yl)benzo[c][1,2,5]thiadiazole / Unkown
HY-W543752 3,5-Di(4H-1,2,4-triazol-4-yl)benzoic acid / Unkown
HY-W577012 1H-1,2,3-Triazole-C4-acid / Unkown
HY-W586928 2-Fluoro-4-(4H-1,2,4-triazol-4-yl)benzoic acid / Unkown
HY-W586933 4-(1H-1,2,4-Triazol-1-yl)-1,3-benzenedicarboxylic acid / Unkown
HY-W588960 4-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)benzoic acid hydrochloride / Unkown
HY-W700970 Methyl 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylate / Unkown
HY-W727488 2-(1H-1,2,4-Triazol-1-yl)acetic acid-d4 / Unkown
HY-W740756 N-Ethyl-3,4-(methylenedioxy)aniline-d5 / Unkown
HY-W754411 rac-Voriconazole-d3 / Unkown
HY-W808862 Ethyl 2-(3,5-di(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)acetate / Unkown
HY-W856008 1,3,5-Tris((1H-1,2,4-triazol-1-yl)methyl)benzene / Unkown
HY-W856032 Tris((1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amine / Unkown
HY-W856051 2,2'-(1H-1,2,4-Triazole-3,5-diyl)dipyridine / Unkown
HY-W856080 2,6-Di(4H-1,2,4-triazol-4-yl)-3a,4,4a,7a,8,8a-hexahydro-4,8-ethenopyrrolo[3,4-f]isoindole-1,3,5,7(2H,6H)-tetraone / Unkown
HY-W856164 4,4',4'',4'''-((Ethene-1,1,2,2-tetrayltetrakis(benzene-4,1-diyl))tetrakis(1H-1,2,3-triazole-4,1-diyl))tetrabenzoic acid / Unkown
HY-W856168 4,4'-(5-Methyl-4H-1,2,4-triazole-3,4-diyl)bis[benzoic acid] / Unkown
HY-W856174 4,4'-Bis((4H-1,2,4-triazol-4-yl)methyl)-1,1'-biphenyl / Unkown
HY-W856203 5-(3,5-Dimethyl-4H-1,2,4-triazol-4-yl)-1,3-benzenedicarboxylic acid / Unkown
HY-W856205 5-(3-Methyl-4H-1,2,4-triazol-4-yl)-1,3-benzenedicarboxylic acid / Unkown
HY-W856206 5-(3-Methyl-5-phenyl-4H-1,2,4-triazol-4-yl)-1,3-benzenedicarboxylic acid / Unkown
HY-W856284 3-Hydroxy-4-(4H-1,2,4-triazol-4-yl)benzoic acid / Unkown
HY-W856365 2,6-Di(4H-1,2,4-triazol-4-yl)pyridine / Unkown
HY-W998843 4-(3,5-Dimethyl-4H-1,2,4-triazol-4-yl)benzoic acid / Unkown
HY-110255C AZD 2066 sulfate Antagonist / Unkown
HY-121366 Kadethrin Inhibitor / Unkown
HY-123437 WAY-120744 Agonist / Unkown
HY-132440S Iso Rizatriptan-d6 / Unkown
HY-168698 (4-(1H-1,2,3-Triazol-4-yl)phenyl)methanol / Unkown
HY-175412 DDTAC / Unkown
HY-177543 5-(4-Methoxvphenol)-4-methyl-3H-1,2-dithiole-3-thione Inducer / Unkown
Inhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990858 Anti-CD47 Antibody (B6.H12) Inhibitor 96.06% Unkown

Orthologs Information

Species Symbol Source ID
Macaca mulatta H1-2 VGNC VGNC:109667
Rattus norvegicus H1-2 RGD RGD:1587893
Bos taurus H1-2 VGNC VGNC:83558
Mus musculus H1-2 MGD MGI:1931526
Others H1-2 NCBI